The 3 major manufacturers of insulin are expanding their assistance programs during the Coronavirus pandemic. Eli Lily, Sanofi and Novo Nordisk are helping insulin dependent patients get access at lower or no cost. All programs had an assistance program before the outbreak, including for those on Medicare. Some of the programs required a $1,000 or more patient reseponsibility before becoming eligible but those requirements are now relaxes. Read more about all three programs here: https://www.fiercepharma.com/pharma/novo-nordisk-expands-free-insulin-program-to-workers-affected-by-covid-19.
You can find programs for prescription assistance for any drug here: https://www.needymeds.org/
Individual programs for insulin are here:
- Eli Lily: http://www.lillycares.com/resources.aspx
- Sanofi: http://www.sanofipatientconnection.com/
- Novo Nordisk: https://www.novocare.com/diabetes-overview/let-us-help/pap.html
Stay Well!
Dave